Alternative Medications for Loperamide-Refractory Diarrhea

First-Line Alternatives Based on Clinical Context

The American Gastroenterological Association recommends bismuth subsalicylate as the most accessible alternative for acute non-bloody diarrhea, providing antimicrobial, anti-inflammatory, and antisecretory effects, although it is less effective than loperamide for symptom control 2
For suspected infectious or traveler's diarrhea, fluoroquinolone antibiotics, such as ciprofloxacin or levofloxacin, are the empirical first-line choice, and can be safely combined with loperamide to hasten symptom resolution in non-dysenteric diarrhea and mild febrile dysentery 2
Bile acid sequestrants, such as cholestyramine, colestipol, or colesevelam, should be considered for chronic diarrhea if bile acid malabsorption is suspected, particularly in patients with ileal disease, resection, or post-cholecystectomy, as recommended by the American College of Gastroenterology 3, 4, 5

The Infectious Diseases Society of America recommends avoiding antimotility agents entirely in situations such as bloody diarrhea, suspected dysentery, fever with diarrhea suggesting invasive infection, suspected or confirmed C. difficile infection, and suspected STEC or shigellosis infection 1

The American College of Gastroenterology suggests that probiotics may reduce symptom severity and duration in immunocompetent adults and children with infectious diarrhea 1
Oral rehydration remains essential regardless of which antidiarrheal agent is chosen, with glucose-containing fluids and electrolyte-rich soups usually sufficient for adults, as recommended by the American Gastroenterological Association 1, 2, 4
Dietary modifications, including avoiding spices, coffee, alcohol, and reducing insoluble fiber intake, and considering lactose avoidance, can help manage diarrhea, as suggested by the American Society of Clinical Oncology 4

The European Society for Medical Oncology recommends budesonide 9 mg once daily for grade 2 diarrhea without bloody stools in patients receiving checkpoint inhibitors, and advises against using loperamide in grade 3-4 immunotherapy-related diarrhea 6